| pubmed-article:9656993 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:9656993 | lifeskim:mentions | umls-concept:C0086418 | lld:lifeskim |
| pubmed-article:9656993 | lifeskim:mentions | umls-concept:C0039194 | lld:lifeskim |
| pubmed-article:9656993 | lifeskim:mentions | umls-concept:C0033684 | lld:lifeskim |
| pubmed-article:9656993 | lifeskim:mentions | umls-concept:C0003316 | lld:lifeskim |
| pubmed-article:9656993 | lifeskim:mentions | umls-concept:C1291802 | lld:lifeskim |
| pubmed-article:9656993 | lifeskim:mentions | umls-concept:C1522138 | lld:lifeskim |
| pubmed-article:9656993 | lifeskim:mentions | umls-concept:C1879547 | lld:lifeskim |
| pubmed-article:9656993 | lifeskim:mentions | umls-concept:C1519878 | lld:lifeskim |
| pubmed-article:9656993 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:9656993 | pubmed:dateCreated | 1998-7-27 | lld:pubmed |
| pubmed-article:9656993 | pubmed:abstractText | Proliferation of HIV-1 in the infected host is characterized by a progressive loss of CD4+ T lymphocytes and consequent dysregulation of the immune system. Both direct and indirect mechanisms have been proposed. We show here that proteins with molecular weights 35, 48, and 110 kDa on stimulated primary human T cells are recognized by neutralizing antibodies against the V3 loop of HIV-1 gp120. Recognition is specific since it can be blocked by a recombinant HIV-1 gp120. Furthermore, these V3 monoclonal antibodies, as well as sera from AIDS patients that recognized these V3-like proteins, induced killing of HIV-1-infected as well as uninfected T cells. This killing was also inhibited by HIV-1 gp120 V3 peptides. These results indicate that the V3 loop shares epitopes with proteins on stimulated T cells. This may be an additional autoimmune mechanism contributing to CD4+ T cell disappearance in AIDS. V3 antibodies have been proposed as potential prophylactic agents. However, if such vaccines were based on certain epitopes, they might induce cross-reacting immune responses with cellular proteins. Vaccine candidates should be evaluated for such potential effects. | lld:pubmed |
| pubmed-article:9656993 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9656993 | pubmed:language | eng | lld:pubmed |
| pubmed-article:9656993 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9656993 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:9656993 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9656993 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9656993 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9656993 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9656993 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9656993 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9656993 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9656993 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9656993 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9656993 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:9656993 | pubmed:month | Jun | lld:pubmed |
| pubmed-article:9656993 | pubmed:issn | 0042-6822 | lld:pubmed |
| pubmed-article:9656993 | pubmed:author | pubmed-author:BrainJ DJD | lld:pubmed |
| pubmed-article:9656993 | pubmed:author | pubmed-author:RogersR ARA | lld:pubmed |
| pubmed-article:9656993 | pubmed:author | pubmed-author:TrujilloJ RJR | lld:pubmed |
| pubmed-article:9656993 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:9656993 | pubmed:day | 20 | lld:pubmed |
| pubmed-article:9656993 | pubmed:volume | 246 | lld:pubmed |
| pubmed-article:9656993 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:9656993 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:9656993 | pubmed:pagination | 53-62 | lld:pubmed |
| pubmed-article:9656993 | pubmed:dateRevised | 2007-11-14 | lld:pubmed |
| pubmed-article:9656993 | pubmed:meshHeading | pubmed-meshheading:9656993-... | lld:pubmed |
| pubmed-article:9656993 | pubmed:meshHeading | pubmed-meshheading:9656993-... | lld:pubmed |
| pubmed-article:9656993 | pubmed:meshHeading | pubmed-meshheading:9656993-... | lld:pubmed |
| pubmed-article:9656993 | pubmed:meshHeading | pubmed-meshheading:9656993-... | lld:pubmed |
| pubmed-article:9656993 | pubmed:meshHeading | pubmed-meshheading:9656993-... | lld:pubmed |
| pubmed-article:9656993 | pubmed:meshHeading | pubmed-meshheading:9656993-... | lld:pubmed |
| pubmed-article:9656993 | pubmed:meshHeading | pubmed-meshheading:9656993-... | lld:pubmed |
| pubmed-article:9656993 | pubmed:meshHeading | pubmed-meshheading:9656993-... | lld:pubmed |
| pubmed-article:9656993 | pubmed:meshHeading | pubmed-meshheading:9656993-... | lld:pubmed |
| pubmed-article:9656993 | pubmed:meshHeading | pubmed-meshheading:9656993-... | lld:pubmed |
| pubmed-article:9656993 | pubmed:meshHeading | pubmed-meshheading:9656993-... | lld:pubmed |
| pubmed-article:9656993 | pubmed:meshHeading | pubmed-meshheading:9656993-... | lld:pubmed |
| pubmed-article:9656993 | pubmed:meshHeading | pubmed-meshheading:9656993-... | lld:pubmed |
| pubmed-article:9656993 | pubmed:meshHeading | pubmed-meshheading:9656993-... | lld:pubmed |
| pubmed-article:9656993 | pubmed:meshHeading | pubmed-meshheading:9656993-... | lld:pubmed |
| pubmed-article:9656993 | pubmed:meshHeading | pubmed-meshheading:9656993-... | lld:pubmed |
| pubmed-article:9656993 | pubmed:meshHeading | pubmed-meshheading:9656993-... | lld:pubmed |
| pubmed-article:9656993 | pubmed:meshHeading | pubmed-meshheading:9656993-... | lld:pubmed |
| pubmed-article:9656993 | pubmed:meshHeading | pubmed-meshheading:9656993-... | lld:pubmed |
| pubmed-article:9656993 | pubmed:meshHeading | pubmed-meshheading:9656993-... | lld:pubmed |
| pubmed-article:9656993 | pubmed:year | 1998 | lld:pubmed |
| pubmed-article:9656993 | pubmed:articleTitle | Shared antigenic epitopes on the V3 loop of HIV-1 gp120 and proteins on activated human T cells. | lld:pubmed |
| pubmed-article:9656993 | pubmed:affiliation | Department of Environmental Health, Harvard School of Public Health, Boston, Massachusetts 02115, USA. | lld:pubmed |
| pubmed-article:9656993 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:9656993 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9656993 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9656993 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9656993 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9656993 | lld:pubmed |
